4.4 Review

Understanding perspectives of signalling mechanisms regulating PEBP1 function

期刊

CELL BIOCHEMISTRY AND FUNCTION
卷 34, 期 6, 页码 394-403

出版社

WILEY
DOI: 10.1002/cbf.3198

关键词

PEBP1; RKIP; cancer; MAPK; neurodegeneration

资金

  1. SERB, New Delhi, India [YSS/2015/000110]
  2. UGC MRP grant [39-240/2010 (SR)]
  3. UGC, India

向作者/读者索取更多资源

Phosphatidylethanolamine-binding protein 1 (PEBP1), also known as Raf kinase inhibitor protein, belongs to PEBP family of proteins. It is known to interact with many proteins that are mainly involved in pathways that monitor cell proliferation and differentiation. PEBP1 in many cells interacts with several pathways, namely MAPK, GRK2, NF-kappa B, etc. that keeps the cell proliferation and differentiation in check. This protein is expressed by many cells in humans, including neurons where it is predominantly involved in production of choline acetyltransferase. Deregulated PEBP1 is known to cause cancer, diabetic nephropathy and neurodegenerative diseases like Alzheimer's and dementia. Recent research led to the discovery of many drugs that mainly target the interaction of PEBP1 with its partners. These compounds are known to bind PEBP1 in its conserved domain which abrogate its association with interacting partners in several different pathways. We outline here the latest developments in understanding of PEBP1 function in maintaining cell integrity. Copyright (C) 2016 John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据